MARTINELLI, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 5.203
EU - Europa 2.248
AS - Asia 1.818
SA - Sud America 256
Continente sconosciuto - Info sul continente non disponibili 78
AF - Africa 48
OC - Oceania 17
Totale 9.668
Nazione #
US - Stati Uniti d'America 5.069
GB - Regno Unito 709
SG - Singapore 567
IT - Italia 547
CN - Cina 424
HK - Hong Kong 245
VN - Vietnam 245
DE - Germania 225
SE - Svezia 211
BR - Brasile 175
FI - Finlandia 113
RU - Federazione Russa 103
BD - Bangladesh 81
UA - Ucraina 79
CA - Canada 67
FR - Francia 67
TR - Turchia 59
ID - Indonesia 34
IN - India 31
KR - Corea 29
IE - Irlanda 28
BG - Bulgaria 27
NL - Olanda 25
BE - Belgio 19
MX - Messico 18
AR - Argentina 17
AU - Australia 17
PL - Polonia 17
CZ - Repubblica Ceca 16
ES - Italia 16
CL - Cile 13
IQ - Iraq 13
JP - Giappone 13
ZA - Sudafrica 13
AE - Emirati Arabi Uniti 12
UZ - Uzbekistan 12
CO - Colombia 11
VE - Venezuela 11
MA - Marocco 10
PE - Perù 10
PH - Filippine 9
PK - Pakistan 9
RO - Romania 9
JM - Giamaica 8
HN - Honduras 7
EC - Ecuador 6
KE - Kenya 6
PY - Paraguay 6
AZ - Azerbaigian 5
CR - Costa Rica 5
DZ - Algeria 5
LT - Lituania 5
AT - Austria 4
BO - Bolivia 4
BZ - Belize 4
CH - Svizzera 4
GP - Guadalupe 4
JO - Giordania 4
MY - Malesia 4
PR - Porto Rico 4
SA - Arabia Saudita 4
DK - Danimarca 3
ET - Etiopia 3
GT - Guatemala 3
HR - Croazia 3
KZ - Kazakistan 3
SN - Senegal 3
SV - El Salvador 3
BY - Bielorussia 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GR - Grecia 2
GY - Guiana 2
KG - Kirghizistan 2
MD - Moldavia 2
MK - Macedonia 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
AG - Antigua e Barbuda 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BM - Bermuda 1
BS - Bahamas 1
CW - ???statistics.table.value.countryCode.CW??? 1
EG - Egitto 1
GA - Gabon 1
GD - Grenada 1
HU - Ungheria 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
LV - Lettonia 1
Totale 9.582
Città #
Ashburn 608
Southend 522
Fairfield 475
Santa Clara 356
Singapore 350
Woodbridge 288
Houston 245
Hong Kong 237
Chandler 236
San Jose 234
Seattle 194
Ann Arbor 176
Cambridge 172
Wilmington 149
Council Bluffs 148
Dearborn 123
Nyköping 123
Jacksonville 120
Modena 96
Hefei 87
Los Angeles 86
Beijing 82
Helsinki 82
New York 82
London 77
Ho Chi Minh City 70
Milan 61
Chicago 57
Hanoi 56
The Dalles 53
Munich 48
Fremont 40
Salt Lake City 35
Bologna 33
Izmir 29
Columbus 28
Dublin 28
Princeton 28
Boardman 27
Lauterbourg 27
Seoul 27
Sofia 27
Eugene 26
Moscow 26
Rome 26
Bremen 25
Buffalo 25
San Diego 25
Jakarta 24
Dallas 22
Brussels 19
São Paulo 18
Tampa 18
Atlanta 16
Warsaw 16
Frankfurt am Main 15
Orem 15
Toronto 14
Montreal 13
Dong Ket 12
Haiphong 12
North Bergen 12
Reggio Emilia 12
Shanghai 12
Brno 11
Phoenix 11
Denver 10
Miami 10
Bari 9
Brooklyn 9
Da Nang 9
Des Moines 9
Redwood City 9
Tashkent 9
Amsterdam 8
Tokyo 8
Turku 8
Can Tho 7
Elk Grove Village 7
Jinan 7
Lancaster 7
Naples 7
Poplar 7
San Francisco 7
Sterling 7
Sydney 7
Baghdad 6
Brasília 6
Castelnuovo Rangone 6
Falls Church 6
Genoa 6
Hillsboro 6
Nairobi 6
Nuremberg 6
Venice 6
Bogotá 5
Caracas 5
Cascina 5
Changsha 5
Charlotte 5
Totale 6.687
Nome #
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 617
Development of hypogammaglobulinemia in patients treated with imatinib for chronic myeloid leukemia or gastrointestinal stromal tumor 459
SVILUPPO DI IPOGAMMAGLOBULINEMIA IN PAZIENTI TRATTATI CON IMATINIB PER LEUCEMIA MIELOIDE CRONICA O TUMORI STROMALI GASTROINTESTINALI 446
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 411
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 390
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 377
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 371
Gene expression profiling of acute promyelocytic leukaemia identifies two subtypes mainly associated with Flt3 mutational status 361
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 353
Increased angiogenesis induced by chronic lymphocytic leukemia B cells is mediated by leukemia-derived Ang2 and VEGF. 347
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 342
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 338
Increased expression of angiopoietin-2 characterizes early B-cell chronic lymphocytic leukemia with poor prognosis 331
INTERACTION BETWEEN ENDOTHELIUM AND CHRONIC LYMPHOCYTIC LEUKEMIA B-CELLS RESCUES FROM APOPTOSIS AND MODULATES GENE EXPRESSION PROFILE OF LEUKEMIC CELLS 328
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 325
ANGPT2 promoter methylation is strongly associated with gene expression and prognosis in chronic lymphocytic leukemia 324
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 320
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. 317
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 316
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 312
Targeting neoplastic B cells and harnessing microenvironment: the “double face” of ibrutinib and idelalisib 296
Immunoglobulin mutational status detected through single-round amplification of partial VH region, represents a good prognostic marker for the clinical outcome in chronic lymphocytic leukemia 296
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms 287
Lenalidomide in chronic lymphocytic leukemia: The present and future in the era of tyrosine kinase inhibitors 283
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms 273
Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia via Kynurenine/Aryl Hydrocarbon Receptor-Mediated MCL1 Modulation 268
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone. 264
Efficacy of imatinib mesylate as maintenance therapy in adults with acute lymphoblastic leukemia in first complete remission 203
Optical genome mapping reveals multiple apoptotic and cell-cycle pathway aberrations in B-cell prolymphocytic leukemia: a report of three cases 71
OPTICAL GENOME MAPPING IDENTIFIES MULTIPLE STRUCTURAL VARIATION AND CATASTROPHIC REARRANGEMENTS IN B-CELL PROLYMPHOCYTIC LEUKEMIA 42
Totale 9.668
Categoria #
all - tutte 33.866
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.866


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022409 0 0 0 25 6 56 23 25 55 45 119 55
2022/2023708 72 90 55 64 94 95 8 80 81 5 28 36
2023/2024488 17 22 28 54 74 46 51 64 14 24 43 51
2024/20251.484 54 41 19 113 236 214 125 89 149 67 165 212
2025/20262.623 203 90 179 259 406 175 372 122 261 256 154 146
2026/2027695 63 162 215 255 0 0 0 0 0 0 0 0
Totale 9.668